- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01468142
Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure
December 19, 2016 updated by: Bernhard Holzgraefe, Karolinska University Hospital
The purpose of this study is the observation of the course of
- the mechanics of the respiratory system
- the endexpiratory lung volume
- and the inflammatory response in patients undergoing treatment with extracorporeal life support (ECLS) due to severe refractory respiratory failure at our department.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
6
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Stockholm
-
Solna, Stockholm, Sweden, 17176
- ECMO Centre Karolinska
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
General hospitals, district hospitals, specialized hospitals,
Description
Inclusion Criteria:
- patients accepted for extracorporeal life support at our department due to the most severe forms of ARDS/respiratory failure not responding to conventional therapy.
Exclusion Criteria:
- malignant disease with a poor prognosis
- massive intracranial bleeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Course of inflammatory parameters and lung function
Time Frame: end of treatment
|
end of treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bernhard Holzgraefe, MD, Karolinska University Hospital
- Study Chair: Anders Larsson, PhD, Uppsala University, Uppsala, Sweden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (ACTUAL)
December 1, 2016
Study Completion (ACTUAL)
December 1, 2016
Study Registration Dates
First Submitted
November 7, 2011
First Submitted That Met QC Criteria
November 8, 2011
First Posted (ESTIMATE)
November 9, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
December 20, 2016
Last Update Submitted That Met QC Criteria
December 19, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011/1282-31/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome, Adult
-
Wolfson Medical CenterUnknown
-
Centre Hospitalier Universitaire de NiceCompletedRespiratory Distress Syndrome,AdultFrance
-
Abbott NutritionTerminatedAcute Lung Injury | Respiratory Distress Syndrome,AdultRussian Federation
-
GlaxoSmithKlineTerminatedLung Injury, Acute and Respiratory Distress Syndrome, AdultUnited Kingdom
-
Amazon UniversitySanta Casa de Misericórdia do ParáCompletedSepsis | HELLP Syndrome | Postpartum Period | Respiratory Distress Syndrome,Adult
-
Michael A. MatthayMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsCompletedRespiratory Distress Syndrome, AdultUnited States
-
Chang Gung Memorial HospitalUnknownRespiratory Distress Syndrome, AdultTaiwan
-
Chinese PLA General HospitalGeneral Hospital of Chinese Armed Police Forces; Beijing Shijitan Hospital,... and other collaboratorsUnknownAcute Lung Injury | Respiratory Distress Syndrome, AdultChina
-
Michael A. MatthayThe University of Texas Health Science Center, Houston; United States Department... and other collaboratorsCompletedRespiratory Distress Syndrome, AdultUnited States
-
Faron Pharmaceuticals LtdSeventh Framework ProgrammeTerminatedRespiratory Distress Syndrome, AdultSpain, United Kingdom, France, Italy, Finland, Czechia, Belgium, Germany